The Pruritus Therapeutics Global Market Report 2023, provides comprehensive information on the pruritus therapeutics market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Pruritus Therapeutics Market’s Growth:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-repor
The global pruritus therapeutics market size is expected to grow from $10.76 billion in 2022 to $11.39 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pruritus therapeutic market is expected to reach $14.02 billion in 2027 at a CAGR of 5.3%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=11907&type=smp
Product innovation is a key trend gaining popularity in the pruritus therapeutics market. Major companies operating in the pruritus therapeutics market focused on developing novel products to strengthen their position in the market. For instance, in August 2021, Fresenius Medical Care AG & Co., a Germany-based product and service provider for people with kidney illnesses, launched KORSUVA (difelikefalin) for a reduction of pruritus related to chronic kidney dysfunction (CKD-aP) in adults having hemodialysis. The Food and Drug Administration (FDA) approved a novel therapeutic injectable drug for managing moderate-to-severe pruritis in patients receiving hemodialysis due to chronic renal failure. It is a first-in-class kappa opioid receptor (KOR) that targets the outer neurological system of the human body. It enhances the safety or effectiveness of the treatment, diagnosis, or prevention of crucial illnesses compared to standard applications.
The pruritus therapeutics market is segmented:
1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Product
2) By Route of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users
North America was the largest region in the pruritus therapeutics market in 2022.
The table of contents in TBRC’s pruritus therapeutics market report includes:
1. Executive Summary
2. Pruritus Therapeutics Market Characteristics
3. Pruritus Therapeutics Market Trends And Strategies
4. Pruritus Therapeutics Market – Macro Economic Scenario
5. Pruritus Therapeutics Market Segmentation
.
.
.
26. South America Pruritus Therapeutics Market
27. Brazil Pruritus Therapeutics Market
28. Middle East Pruritus Therapeutics Market
29. Africa Pruritus Therapeutics Market
30. Pruritus Therapeutics Market Competitive Landscape And Company Profiles
Top Major Players:
- Pfizer Inc
- Johnson & Johnson
- AbbVie Inc
- Sanofi S.A
- Bristol-Myers Squibb Company
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
